Hitotsuyanagi Yukio, Sasaki Shin-Ichi, Matsumoto Yuji, Yamaguchi Kentaro, Itokawa Hideji, Takeya Koichi
School of Pharmacy, Tokyo University of Pharmacy and Life Science, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
J Am Chem Soc. 2003 Jun 18;125(24):7284-90. doi: 10.1021/ja021131y.
Three epimers of a natural cyclic hexapeptide RA-VII were prepared via formation of oxazoles from thioamides or thioimidates of RA-VII followed by hydrolysis. They are the epimers at l-Ala-1, d-Ala-2, and d-Ala-4, respectively. The one having l-Ala-1 adopted trans-cis-trans-trans-trans-trans (t-c-t-t-t-t) amide configurations in the crystal, a type-VI beta-turn for residues 1-4 stabilized by one intramolecular hydrogen bond between Ala-4 NH and l-Ala-1 C = O, and in CDCl(3) existed as a mixture of six conformers, of which the major conformer was very similar to that in the crystal, but quite different from that of RA-VII in solution. The second epimer, having d-Ala-2 had in the crystalline state t-t-t-t-c-t amide configurations, a gamma-turn at Tyr-3 stabilized by two intramolecular hydrogen bonds between d-Ala-2 NH and Ala-4 C = O and between Ala-4 NH and d-Ala-2 C = O, and existed in CDCl(3) as a single conformer, the structure of which was very similar to its crystal structure, and to the crystal structure of peptide 25 except for the backbone and the side chains at residues 1 and 2. The third epimer, having d-Ala-4 had t-c-t-t-c-t amide configurations in the crystal, a type-VI beta-turn for residues 1-4 as observed in the first epimer, and in CDCl(3) existed in three conformers, of which the major one was similar to that in the crystal but different from that of RA-VII in solution. The three epimers showed very weak cytotoxicity on P-388 leukemia cells, which may be because of their conformational differences from the active conformation of RA-VII.
通过由RA-VII的硫代酰胺或硫代亚胺形成恶唑,然后水解,制备了天然环状六肽RA-VII的三种差向异构体。它们分别是L-Ala-1、D-Ala-2和D-Ala-4位的差向异构体。具有L-Ala-1的异构体在晶体中采用反式-顺式-反式-反式-反式-反式(t-c-t-t-t-t)酰胺构型,1-4位残基形成VI型β-转角,由Ala-4的NH与L-Ala-1的C=O之间的一个分子内氢键稳定,在CDCl₃中以六种构象的混合物形式存在,其中主要构象与晶体中的非常相似,但与溶液中RA-VII的构象有很大不同。第二种差向异构体,具有D-Ala-2,在结晶状态下具有t-t-t-t-c-t酰胺构型,Tyr-3处有一个γ-转角,由D-Ala-2的NH与Ala-4的C=O之间以及Ala-4的NH与D-Ala-2的C=O之间的两个分子内氢键稳定,在CDCl₃中以单一构象存在,其结构与其晶体结构非常相似,与肽25的晶体结构相似,除了1和2位残基的主链和侧链。第三种差向异构体,具有D-Ala-4,在晶体中具有t-c-t-t-c-t酰胺构型,如在第一种差向异构体中观察到的1-4位残基的VI型β-转角,在CDCl₃中以三种构象存在,其中主要构象与晶体中的相似,但与溶液中RA-VII的构象不同。这三种差向异构体对P-388白血病细胞显示出非常弱的细胞毒性,这可能是由于它们与RA-VII的活性构象存在构象差异。